scitechkevin's profile picture. Science writer and enthusiast, dad, bicyclist, musician. Views are my own.

Kevin Costa

@scitechkevin

Science writer and enthusiast, dad, bicyclist, musician. Views are my own.

Kevin Costa reposted

We’re back again, this time with details on our models for de novo design and new, open sourced data on functionality and developability, going beyond binding. We show one design has 3x higher potency than trastuzumab! Paper: biorxiv.org/content/10.110… Data: github.com/AbSciBio/unloc…

amirshanehsaz's tweet image. We’re back again, this time with details on our models for de novo design and new, open sourced data on functionality and developability, going beyond binding. We show one design has 3x higher potency than trastuzumab!

Paper: biorxiv.org/content/10.110…
Data: github.com/AbSciBio/unloc…

Kevin Costa reposted

We’re excited to announce our new strategic partnership with @precisionlifeAI. Under the partnership, we’ll be working together to discover and develop a shared pipeline of biotherapeutics for up to five mutually agreed-upon targets and indications. investors.absci.com/news-releases/…

abscibio's tweet image. We’re excited to announce our new strategic partnership with @precisionlifeAI. Under the partnership, we’ll be working together to discover and develop a shared pipeline of biotherapeutics for up to five mutually agreed-upon targets and indications. investors.absci.com/news-releases/…

Kevin Costa reposted

We @abscibio are excited to unveil IgDesign™ @NeurIPSConf and present our work at @workshopmlsb @AI4D3 @genbio_workshop! IgDesign is an antibody inverse folding model that we have experimentally validated in our lab. Read the paper here: biorxiv.org/content/10.110… #NeurIPS2023

amirshanehsaz's tweet image. We @abscibio are excited to unveil IgDesign™ @NeurIPSConf and present our work at @workshopmlsb @AI4D3 @genbio_workshop! IgDesign is an antibody inverse folding model that we have experimentally validated in our lab. Read the paper here: biorxiv.org/content/10.110… #NeurIPS2023

Kevin Costa reposted

We're excited to announce our new collaboration with @AstraZeneca! This collaboration combines Absci's Integrated Drug Creation™ platform with AstraZeneca's expertise in oncology with the goal of accelerating the discovery of a potential new cancer treatment candidate.

abscibio's tweet image. We're excited to announce our new collaboration with @AstraZeneca! This collaboration combines Absci's Integrated Drug Creation™ platform with AstraZeneca's expertise in oncology with the goal of accelerating the discovery of a potential new cancer treatment candidate.

Kevin Costa reposted

We are excited to announce our new collaboration with Almirall! We’ll be working together to develop and commercialize AI-designed therapeutics to fight chronic and debilitating dermatological diseases. investors.absci.com/news-releases/…

abscibio's tweet image. We are excited to announce our new collaboration with Almirall! We’ll be working together to develop and commercialize AI-designed therapeutics to fight chronic and debilitating dermatological diseases. investors.absci.com/news-releases/…

What a strange and wonderful performance! Thank you @DrewEndy @specterm @ahmedbest. @SynBioBeta

scitechkevin's tweet image. What a strange and wonderful performance! Thank you @DrewEndy @specterm @ahmedbest. @SynBioBeta

You heard it here first: data is more important than models. Code to Cure panel moderated by @SeanRMcClain . @SynBioBeta @abscibio

scitechkevin's tweet image. You heard it here first: data is more important than models. Code to Cure panel moderated by @SeanRMcClain . @SynBioBeta @abscibio

E. coli is the unlikely hero of generative AI. Today it’s pharma, tomorrow it’s food, the next day it will be the stars! @SynBioBeta @abscibio

scitechkevin's tweet image. E. coli is the unlikely hero of generative AI. Today it’s pharma, tomorrow it’s food, the next day it will be the stars! @SynBioBeta @abscibio

Creating drugs at the speed of Ai! ⁦@abscibio⁩ ⁦@SynBioBeta⁩ ⁦@SeanRMcClain

scitechkevin's tweet image. Creating drugs at the speed of Ai! ⁦@abscibio⁩  ⁦@SynBioBeta⁩ ⁦@SeanRMcClain⁩

Thrilled to be back at @synbiobeta this year! You can always count on @johncumbers for a big start to a big event!

scitechkevin's tweet image. Thrilled to be back at @synbiobeta this year! You can always count on @johncumbers for a big start to a big event!

I adore you, @PlazaAccount Aubrey Plaza, but why are you propagandizing against sustainable milk? 💔


Alex Phillipidis at @genbio does a great job of capturing what Absci does — and how it can go after the hardest part of the antibody with #generativeai and #synbio to create better #biologics for patients faster than ever. linkedin.com/posts/activity…


Kevin Costa reposted

Trillion. With a T. #synbio Green industries could be worth $10.3 trln to economy by 2050 - study | Reuters reuters.com/business/susta…


Kevin Costa reposted

Today, we announce a breakthrough in AI drug design: We’re the first to design AND validate new therapeutic antibodies with zero-shot #generativeAI. Read about it in our preprint: biorxiv.org/content/10.110… #JPM23


Loading...

Something went wrong.


Something went wrong.